Skip to main content

Nonprofit · EIN 81-1231641

CURE GLAUCOMA FOUNDATION

Tax-exempt · DALLAS, TX 75231

Financials

$268K$235K2024
Revenue Expenses · by fiscal year end
Financials of CURE GLAUCOMA FOUNDATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$267,724$234,701$33,023$165,083$61$165,022
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$255,693
Program service revenue
$0
Investment income
$12,031
Other revenue
$0

Expenses

Grants and similar amounts paid
$25,125
Compensation of officers, directors and key employees
$25,738
Salaries, compensation and benefits (total)
$32,295
Professional fundraising fees
$0
Accounting fees
$1,775
Occupancy
$1,500
Depreciation
$747
Program services (functional)
$179,062
Management and general (functional)
$11,641
Fundraising (functional)
$43,998

Balance sheet and other

Total assets, start of year
$132,060
Total assets, end of year
$165,083
Total liabilities, end of year
$61
Net assets, end of year
$165,022
Land, buildings and equipment
$2,756
Net assets without donor restrictions
$165,022
Gross receipts
$267,724
Employees
1
Volunteers
20
Year formed
2014
State of legal domicile
TX

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
Mike KettlesExec Dir/Treas
Trustee or director, Officer
40$25,738
W Stephen LovePresident
Trustee or director, Officer
1$0
Helen L Kornmann MD PhDSecretary
Trustee or director, Officer
1$0
Davinder S Grover MD MPHDirector
Trustee or director
1$0
Joseph K HaggertyDirector
Trustee or director
1$0
Bradley F Jost MDDirector
Trustee or director
1$0
Ronald L Fellman MDDirector
Trustee or director
1$0
Joan Taylor MDDirector
Trustee or director
1$0
Orlando CarvalhoDirector
Trustee or director
1$0

Address and contacts

Address (IRS master file)
10740 N CENTRAL EXPY STE 300, DALLAS, TX 75231-2168
In care of
% MICHAEL KETTLES
Principal officer (990 for 2024)
Mike Kettles, 10740 N Central Expressway 300, Dallas, TX 75231
Signed the 990
Mike Kettles, Executive Director
Phone
(214) 765-9716
Return prepared by
Acker & Company

Mission

The mission of Cure Glaucoma is to improve glaucoma by funding transformational research, disseminating knowledge and expanding treatment availability through global outreach efforts.

990 for the year ended December 31, 2024

Program accomplishments

  • CGFs mission is to improve quality care for all people, fund transformational research and disseminate knowledge through global outreach efforts.
    Expenses $179,062

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
81-1231641
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (509(a)(2))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2016
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$165,083
Income (IRS master file)
$267,724

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024–––IRS
990December 2023$484,375$543,318$132,060IRS
990December 2022$794,009$884,180$184,928IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2019–––IRS
990December 2018–––IRS

990-N: the IRS publishes only the latest e-Postcard per organization; earlier years appear here as 990.tax collects the monthly files. 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS.

Questions about CURE GLAUCOMA FOUNDATION

What is the EIN of CURE GLAUCOMA FOUNDATION?
The employer identification number (EIN) of CURE GLAUCOMA FOUNDATION is 81-1231641.
Is CURE GLAUCOMA FOUNDATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2016.
Are donations to CURE GLAUCOMA FOUNDATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does CURE GLAUCOMA FOUNDATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of CURE GLAUCOMA FOUNDATION due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did CURE GLAUCOMA FOUNDATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of CURE GLAUCOMA FOUNDATION?
The 990 for the year ended December 31, 2024 names Mike Kettles.
Who are the officers and directors of CURE GLAUCOMA FOUNDATION?
The 990 for the year ended December 31, 2024 lists 9 people; 1 received compensation from the organization, the highest $25,738 (Mike Kettles, Exec Dir/Treas).
How much revenue does CURE GLAUCOMA FOUNDATION have?
On its 990 for the year ended December 31, 2024 it reported revenue of $267,724, expenses of $234,701 and total assets of $165,083 at year end.

Other nonprofits in DALLAS

All nonprofits in DALLAS · Texas · International, foreign affairs and national security